diazepam has been researched along with ro 4956371 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitter-Stoll, N; Boissin, P; Borroni, E; Büttelmann, B; Ceccarelli, S; Clemann, N; David, B; Funk, C; Guba, W; Harrison, A; Hartung, T; Honer, M; Huwyler, J; Jaeschke, G; Kolczewski, S; Kuratli, M; Lindemann, L; Niederhauser, U; Pähler, A; Peters, JU; Petersen, A; Porter, RH; Prinssen, E; Ricci, A; Rueher, D; Rueher, M; Schneider, M; Spooren, W; Spurr, P; Stoll, T; Tännler, D; Vieira, E; Wettstein, JG; Wichmann, J | 1 |
1 other study(ies) available for diazepam and ro 4956371
| Article | Year |
|---|---|
Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Topics: Allosteric Regulation; Animals; Depression; Dose-Response Relationship, Drug; Drug Discovery; Fragile X Syndrome; Humans; Imidazoles; Macaca mulatta; Male; Mice; Mice, Inbred Strains; Molecular Structure; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Structure-Activity Relationship | 2015 |